HIC
ABBV icon

Holderness Investments Company’s AbbVie ABBV Stock Holding History

Holderness Investments Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.04M Buy
23,153
+1,150
+5% +$255K 1.01% 21
2025
Q4 		$5.03M Buy
22,003
+124
+0.6% +$28.2K 1.02% 18
2025
Q3 		$5.07M Sell
21,879
-1,734
-7% -$353K 1.03% 18
2025
Q2 		$4.38M Sell
23,613
-307
-1% -$57.1K 0.94% 22
2025
Q1 		$5.01M Buy
23,920
+36
+0.2% +$7K 1.17% 19
2024
Q4 		$4.24M Sell
23,884
-255
-1% -$46.9K 0.94% 25
2024
Q3 		$4.77M Buy
24,139
+281
+1% +$52.4K 1.04% 20
2024
Q2 		$4.09M Sell
23,858
-536
-2% -$88.8K 0.97% 20
2024
Q1 		$4.44M Sell
24,394
-1
-0% -$172 1.09% 18
2023
Q4 		$3.78M Sell
24,395
-271
-1% -$39.5K 1.04% 25
2023
Q3 		$3.68M Sell
24,666
-142
-0.6% -$20.8K 1.43% 13
2023
Q2 		$3.34M Buy
24,808
+107
+0.4% +$15.7K 1.23% 18
2023
Q1 		$3.94M Sell
24,701
-72
-0.3% -$11K 1.57% 13
2022
Q4 		$4M Sell
24,773
-122
-0.5% -$18.7K 1.73% 10
2022
Q3 		$3.34M Sell
24,895
-230
-0.9% -$33K 1.52% 13
2022
Q2 		$3.85M Sell
25,125
-1,176
-4% -$180K 1.61% 13
2022
Q1 		$4.26M Buy
26,301
+183
+0.7% +$26.6K 1.42% 14
2021
Q4 		$3.54M Buy
26,118
+10
+0% +$1.18K 1.04% 20
2021
Q3 		$2.82M Sell
26,108
-3,184
-11% -$364K 0.93% 28
2021
Q2 		$3.3M Buy
29,292
+60
+0.2% +$6.76K 1.09% 20
2021
Q1 		$3.16M Buy
29,232
+221
+0.8% +$23.6K 1.14% 19
2020
Q4 		$3.11M Sell
29,011
-364
-1% -$35K 1.21% 19
2020
Q3 		$2.57M Buy
29,375
+1,700
+6% +$160K 1.06% 26
2020
Q2 		$2.72M Buy
27,675
+2,362
+9% +$208K 1.21% 20
2020
Q1 		$1.93M Buy
25,313
+975
+4% +$83K 1.09% 24
2019
Q4 		$2.15M Buy
24,338
+901
+4% +$74.8K 0.92% 30
2019
Q3 		$1.77M Buy
23,437
+1,271
+6% +$87.1K 0.83% 34
2019
Q2 		$1.61M Buy
22,166
+1,005
+5% +$79K 0.73% 38
2019
Q1 		$1.71M Buy
21,161
+748
+4% +$61.2K 0.82% 35
2018
Q4 		$1.88M Buy
20,413
+4,930
+32% +$434K 1.03% 27
2018
Q3 		$1.46M Buy
15,483
+1,560
+11% +$148K 0.66% 45
2018
Q2 		$1.29M Buy
13,923
+135
+1% +$13.2K 0.63% 47
2018
Q1 		$1.3M Sell
13,788
-1,073
-7% -$118K 0.64% 47
2017
Q4 		$1.44M Sell
14,861
-81
-0.5% -$7.63K 0.71% 43
2017
Q3 		$1.33M Buy
14,942
+754
+5% +$57.4K 0.69% 44
2017
Q2 		$1.03M Buy
14,188
+762
+6% +$51.2K 0.55% 60
2017
Q1 		$875K Sell
13,426
-71
-0.5% -$4.46K 0.44% 72
2016
Q4 		$845K Buy
13,497
+100
+0.7% +$6.1K 0.75% 47
2016
Q3 		$845K Buy
13,397
+1,028
+8% +$66.5K 0.85% 45
2016
Q2 		$766K Sell
12,369
-815
-6% -$49.7K 0.77% 46
2016
Q1 		$753K Buy
13,184
+128
+1% +$7.13K 0.72% 52
2015
Q4 		$773K Buy
13,056
+816
+7% +$47K 0.77% 47
2015
Q3 		$666K Buy
12,240
+713
+6% +$46.4K 0.7% 52
2015
Q2 		$774K Buy
11,527
+900
+8% +$58.8K 0.79% 47
2015
Q1 		$622K Hold
10,627
– – 0.63% 55
2014
Q4 		$695K Buy
+10,627
New +$670K 0.71% 50

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Holderness Investments Company's ABBV Position: Q1 2026 in Review

Holderness Investments Company increased its AbbVie (ABBV) stake by 5.2% in Q1 2026, buying an estimated $255K and bringing the position to 23,153 shares worth $5.04M. The position accounts for 1.01% of the portfolio, ranked #21.

Holderness Investments Company first reported a position in ABBV in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.07M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Holderness Investments Company held 23,153 shares of AbbVie worth $5.04M as of Q1 2026.
  • Holderness Investments Company bought 1,150 AbbVie shares in Q1 2026, an estimated $255K.
  • AbbVie made up 1.01% of Holderness Investments Company's portfolio in Q1 2026, its #21 holding.
  • Holderness Investments Company first reported a position in AbbVie in Q4 2014 and has held it in 46 quarters since.
  • Holderness Investments Company's AbbVie position peaked at $5.07M in Q3 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.